Cortex Room, Wyss Institute
201 Brookline Avenue, Boston, MA 02215
Enhancing Gamma Delta (γδ) T-Cell Therapies Through Engineered Biochemical and Mechanical Microenvironments
Gamma delta (γδ) T-cells comprise approximately 0.5-10% of T-cells in human peripheral blood and have recently gained interest in the context of adoptive T-cell therapy. Notably, tumor-infiltrating γδ T-cells have been identified as a significant positive prognostic population, in some settings showing stronger associations with favorable outcomes than conventional CD8+ or CD4+ αβ T-cells, which have been the primary focus of most cell therapy approaches. Efforts to improve γδ T-cell expansion and cytotoxic function using cytokines, genetic engineering, and alternative activation models have yielded mixed results, in part because current expansion systems fail to recapitulate the mechanical and biochemical milieu encountered in vivo. Building on observations that tissue-resident γδ T-cells exhibit phenotypes distinct from those found in blood, we employed an engineered collagen matrix designed to recapitulate viscoelasticity, a key feature of tissues, to examine its effects on γδ T-cell differentiation, phenotype, and cytotoxic potential. Using this system, we identified viscoelasticity as a modulator of γδ T-cell biology and as a driver of distinct phenotypic and cytotoxic outcomes. To address persistent challenges in γδ T-cell expansion, we also developed a tunable alginate microgel system in which surface presentation of biochemical cues could be varied to determine how increased stimulation density influences γδ T-cell expansion and phenotype. This microgel platform further enabled us to investigate how prior antigen experience shapes γδ T-cell expansion potential and function. Altogether, this thesis demonstrates that engineering biochemical and mechanical environments that recapitulate in vivo γδ T-cell niches is essential for maximizing expansion potential and improving efficacy in the context of cancer immunotherapy.
Thesis Supervisor:
David J Mooney, PhD
Robert P. Pinkas Family Professor of Bioengineering, Harvard John A. Paulson School of Engineering and Applied Science
Thesis Committee Chair:
Sangeeta Bhatia, MD, PhD
John J. and Dorothy Wilson Professor of Health Sciences and Technology and of Electrical Engineering and Computer Science, MIT
Thesis Reader:
Kai Wucherpfennig, MD, PhD
Chair, Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute
Nancy Lurie Marks Professor of Neurology in the field of Medical Oncology, Harvard Medical School
________________________________________________________________________________________
For in person
To ensure you have access to the building, please fill out this brief [Form] by April 29 to be included in the guest list
Zoom Invitation
Favour Obuseh is inviting you to a scheduled Zoom meeting
Topic: Favour Obuseh MEMP PhD Thesis Defense
Time: Monday, May 4, 2026, 9:00 AM Eastern Time (US and Canada)
Your participation is important to us: please notify hst [at] mit.edu (hst[at]mit[dot]edu), at least 3 business days in advance, if you require accommodations in order to access this event.
Join Zoom Meeting
https://mit.zoom.us/j/95986110173
Password: 212709
One tap mobile
+16465588656,,95986110173# US (New York)
+16699006833,,95986110173# US (San Jose)
Meeting ID: 959 8611 0173
US: +1 646 558 8656 or +1 669 900 6833
International Numbers: https://mit.zoom.us/u/ax6BGKrpW
Join by SIP
95986110173 [at] zoomcrc.com (95986110173[at]zoomcrc[dot]com)
Join by Skype for Business
https://mit.zoom.us/skype/95986110173